• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及人群中耐药性高血压的流行率、预测因素和结局。

Prevalence, Predictors, and Outcomes of Resistant Hypertension in Egyptian Population.

机构信息

Assistant professor of cardiovascular medicine, cardiovascular department, faculty of Medicine, Tanta University, EG.

Lecturer of endocrinology, internal medicine department, faculty of Medicine, Tanta University, EG.

出版信息

Glob Heart. 2023 Jun 14;18(1):31. doi: 10.5334/gh.1211. eCollection 2023.

DOI:10.5334/gh.1211
PMID:37334401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10275134/
Abstract

BACKGROUND

Hypertension is a leading problem; it affects around thirty million adult Egyptians, according to the last national registry. The exact prevalence of resistant hypertension (RH) in Egypt wasn't spotted before. The purpose of this study was to determine the prevalence, predictors, and impact on adverse cardiovascular outcomes among adult Egyptians with RH.

METHODS

The present study examined a cohort of 990 hypertensive patients who were divided into two groups based on their blood pressure control; group I (n = 842) patients who achieved blood pressure control and group II (n = 148) patients who met the RH definition criteria. All patients underwent a close follow-up for one year to evaluate the major cardiovascular events.

RESULTS

The prevalence of RH was 14.9%. The main predictors impacting the cardiovascular outcomes of RH were advanced age (≥65 years), the presence of chronic kidney diseases, a BMI ≥ 30 kg/m, and NSAID use. After one year of follow-up, the RH group displayed noticeably higher rates of major cardiovascular events, including new-onset atrial fibrillation (6.8% vs. 2.5%, P = 0.006), cerebral stroke (4.1% vs. 1.2%, P = 0.011), myocardial infarction (4.7% vs. 1.3%, P = 0.004), and acute heart failure (4.7% vs. 1.8%, P = 0.025).

CONCLUSION

The prevalence of RH in Egypt is moderately high. Patients with RH have a far higher risk of cardiovascular events than those whose blood pressure is within control.

摘要

背景

高血压是一个主要问题;根据最近的国家登记,它影响了大约 3000 万埃及成年人口。以前没有发现埃及确切的耐药性高血压(RH)的患病率。本研究的目的是确定埃及成年 RH 患者的患病率、预测因素及其对不良心血管结局的影响。

方法

本研究检查了 990 例高血压患者的队列,根据血压控制情况将他们分为两组;第 I 组(n = 842)患者血压得到控制,第 II 组(n = 148)患者符合 RH 定义标准。所有患者接受了为期一年的密切随访,以评估主要心血管事件。

结果

RH 的患病率为 14.9%。影响 RH 心血管结局的主要预测因素是年龄较大(≥65 岁)、存在慢性肾脏疾病、BMI≥30kg/m 和 NSAID 用药。经过一年的随访,RH 组主要心血管事件的发生率明显更高,包括新发心房颤动(6.8% vs. 2.5%,P=0.006)、脑卒(4.1% vs. 1.2%,P=0.011)、心肌梗死(4.7% vs. 1.3%,P=0.004)和急性心力衰竭(4.7% vs. 1.8%,P=0.025)。

结论

埃及 RH 的患病率中等偏高。RH 患者发生心血管事件的风险远高于血压控制患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea9/10275134/4e1de3216b8e/gh-18-1-1211-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea9/10275134/4e1de3216b8e/gh-18-1-1211-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ea9/10275134/4e1de3216b8e/gh-18-1-1211-g1.jpg

相似文献

1
Prevalence, Predictors, and Outcomes of Resistant Hypertension in Egyptian Population.埃及人群中耐药性高血压的流行率、预测因素和结局。
Glob Heart. 2023 Jun 14;18(1):31. doi: 10.5334/gh.1211. eCollection 2023.
2
Prevalence, predictors, and outcomes of both true- and pseudo-resistant hypertension in the action to control cardiovascular risk in diabetes trial: a cohort study.在糖尿病心血管风险控制行动试验中,真正和假性耐药高血压的患病率、预测因素和结局:一项队列研究。
Hypertens Res. 2021 Nov;44(11):1471-1482. doi: 10.1038/s41440-021-00739-6. Epub 2021 Sep 13.
3
Resistant hypertension, patient characteristics, and risk of stroke.难治性高血压、患者特征与中风风险。
PLoS One. 2014 Aug 4;9(8):e104362. doi: 10.1371/journal.pone.0104362. eCollection 2014.
4
Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.通过动态血压监测确定的孤立诊室和真性耐药高血压的患病率及临床特征。
Chronobiol Int. 2013 Mar;30(1-2):207-20. doi: 10.3109/07420528.2012.701135. Epub 2012 Oct 19.
5
The prevalence and predictors of resistant hypertension in high-risk overweight and obese patients: A cross-sectional study based on the 2017 ACC/AHA guidelines.超重和肥胖高危患者中耐药性高血压的患病率及其预测因素:基于 2017ACC/AHA 指南的横断面研究。
J Clin Hypertens (Greenwich). 2019 Oct;21(10):1507-1515. doi: 10.1111/jch.13666. Epub 2019 Aug 26.
6
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: results from the MINISAL-SIIA study program.意大利高血压中心随访的患者样本中难治性高血压的患病率及决定因素:MINISAL-SIIA研究项目的结果
J Hum Hypertens. 2016 Nov;30(11):703-708. doi: 10.1038/jhh.2016.6. Epub 2016 Mar 3.
7
Blood pressure targets in adults with hypertension.高血压成人的血压目标。
Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD004349. doi: 10.1002/14651858.CD004349.pub3.
8
Resistant Hypertension and Risk of Adverse Events in Individuals With Type 1 Diabetes: A Nationwide Prospective Study.1 型糖尿病患者的耐药性高血压与不良事件风险:一项全国范围的前瞻性研究。
Diabetes Care. 2020 Aug;43(8):1885-1892. doi: 10.2337/dc20-0170. Epub 2020 May 22.
9
Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.冠心病患者中治疗抵抗性高血压的患病率、预测因素和结局。
Am J Med. 2014 Jan;127(1):71-81.e1. doi: 10.1016/j.amjmed.2013.07.038. Epub 2013 Nov 7.
10
Resistant and undertreated hypertension in patients with chronic kidney disease: data from the PATRIOTIC survey.慢性肾脏病患者的耐药和治疗不足的高血压:来自 PATRIOTIC 调查的数据。
Clin Exp Hypertens. 2018;40(8):784-791. doi: 10.1080/10641963.2018.1433193. Epub 2018 Mar 6.

引用本文的文献

1
Prevalence and determinants of apparent treatment-resistant hypertension among patients in South African primary care: a single-centre observational study.南非初级保健患者中貌似难治性高血压的患病率及影响因素:一项单中心观察性研究
BMC Cardiovasc Disord. 2025 May 19;25(1):373. doi: 10.1186/s12872-025-04813-6.
2
Mendelian randomization studies of lifestyle-related risk factors for stroke: a systematic review and meta-analysis.基于孟德尔随机化的生活方式相关脑卒中风险因素研究:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2024 Nov 4;15:1379516. doi: 10.3389/fendo.2024.1379516. eCollection 2024.

本文引用的文献

1
Epidemiology of Resistant Hypertension in Canada.加拿大耐药性高血压的流行病学研究。
Can J Cardiol. 2022 May;38(5):681-687. doi: 10.1016/j.cjca.2022.01.029. Epub 2022 Feb 3.
2
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.全球高血压患病率趋势及 1990 至 2019 年治疗和控制进展情况:1040 万参与者、1201 项人群代表性研究的汇总分析
Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. Epub 2021 Aug 24.
3
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.
强化与标准血压控制的试验最终报告。
N Engl J Med. 2021 May 20;384(20):1921-1930. doi: 10.1056/NEJMoa1901281.
4
Adverse Health Outcomes Associated With Refractory and Treatment-Resistant Hypertension in the Chronic Renal Insufficiency Cohort.与慢性肾功能不全队列中难治性和治疗抵抗性高血压相关的不良健康结局。
Hypertension. 2021 Jan;77(1):72-81. doi: 10.1161/HYPERTENSIONAHA.120.15064. Epub 2020 Nov 9.
5
Prevalence and prognosis of the 2018 vs 2008 AHA definitions of apparent treatment-resistant hypertension in high-risk hypertension patients.2018 年与 2008 年 AHA 定义的明显治疗抵抗性高血压在高危高血压患者中的患病率和预后。
J Clin Hypertens (Greenwich). 2020 Nov;22(11):2093-2102. doi: 10.1111/jch.14043. Epub 2020 Sep 20.
6
Hypertension Prevalence Among Adults Aged 18 and Over: United States, 2017-2018.成年人高血压患病率:18 岁及以上人群,美国,2017-2018 年。
NCHS Data Brief. 2020 Apr(364):1-8.
7
Treatment resistant hypertension among ambulatory hypertensive patients: A cross sectional study.门诊高血压患者中治疗抵抗性高血压:一项横断面研究。
PLoS One. 2020 Apr 28;15(4):e0232254. doi: 10.1371/journal.pone.0232254. eCollection 2020.
8
Registry of the Egyptian specialized hypertension clinics: patient risk profiles and geographical differences.埃及专门高血压诊所登记处:患者风险概况和地域差异。
J Hum Hypertens. 2020 Jul;34(7):520-527. doi: 10.1038/s41371-019-0265-0. Epub 2019 Sep 26.
9
Prevalence of Apparent Treatment-Resistant Hypertension in the United States.美国显性治疗抵抗性高血压的流行情况。
Hypertension. 2019 Feb;73(2):424-431. doi: 10.1161/HYPERTENSIONAHA.118.12191.
10
Resistant and refractory hypertension: two sides of the same disease?顽固性高血压与难治性高血压:同一种疾病的两面?
J Bras Nefrol. 2019 Apr-Jun;41(2):266-274. doi: 10.1590/2175-8239-jbn-2018-0108. Epub 2018 Dec 6.